Industry: Service & Software
Published Date: 2026-07-15
Pages: 105 Pages
Report ld: 6975044
Request Sample
Customized Report
Biobanking Services Market Size(US$)

CAGR 2026-2032
7.3%
Market Size,2032
USD 4,905
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Biobanking Services was estimated to be worth US$ 3016 million in 2025 and is projected to reach US$ 4905 million, growing at a CAGR of 7.3% from 2026 to 2032.
Biobanking is a procedure to collect and preserve biological materials that can be further used for diagnosis, biodiversity studies, and research.
The North American market for Biobanking Services was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Biobanking Services was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for Biobanking Services was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the Biobanking Services market include Qiagen N.V., Hamilton, Brooks Automation, TTP Labtech, VWR, Promega, LGC, Boca Biolistics, Thermo Fisher, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for Biobanking Services, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Biobanking Services market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Biobanking Services.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.
Chapter 2: Provides a detailed analysis of the Biobanking Services companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Biobanking Services revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Biobanking Services revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.
Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Biobanking Services Product Introduction
1.2 Global Biobanking Services Market Size Forecast (2021–2032)
1.3 Biobanking Services Market Trends & Drivers
1.3.1 Biobanking Services Industry Trends
1.3.2 Biobanking Services Market Drivers & Opportunities
1.3.3 Biobanking Services Market Challenges
1.3.4 Biobanking Services Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Biobanking Services Players Revenue Ranking (2025)
2.2 Global Biobanking Services Revenue by Company (2021–2026)
2.3 Key Companies’ R&D and Operations Footprint and Headquarters
2.4 Key Companies Biobanking Services Product Offerings
2.5 Key Companies General Availability (GA) Timeline for Biobanking Services
2.6 Biobanking Services Market Competitive Analysis
2.6.1 Biobanking Services Market Concentration Rate (2021–2026)
2.6.2 Top 5 and Top 10 Global Companies by Biobanking Services Revenue in 2025
2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Biobanking Services revenue, 2025
2.7 Mergers & Acquisitions and Expansion
3 Segmentation Biobanking Services Market Classification
3.1 Introduction by Type
3.1.1 Blood Products
3.1.2 Human Tissues
3.1.3 Cell Lines
3.1.4 Nucleic Acids
3.1.5 Global Biobanking Services Sales Value by Type
3.1.5.1 Global Biobanking Services Sales Value by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global Biobanking Services Sales Value, by Type (2021–2032)
3.1.5.3 Global Biobanking Services Sales Value, by Type (%), 2021–2032
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Regenerative Medicine
4.1.2 Life Science
4.1.3 Clinical Research
4.2 Global Biobanking Services Sales Value by Application
4.2.1 Global Biobanking Services Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Biobanking Services Sales Value by Application (2021–2032)
4.2.3 Global Biobanking Services Sales Value by Application (%), 2021–2032
5 Segmentation by Region
5.1 Global Biobanking Services Sales Value by Region
5.1.1 Global Biobanking Services Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Biobanking Services Sales Value by Region (2021–2026)
5.1.3 Global Biobanking Services Sales Value by Region (2027–2032)
5.1.4 Global Biobanking Services Sales Value by Region (%), 2021–2032
5.2 North America
5.2.1 North America Biobanking Services Sales Value, 2021–2032
5.2.2 North America Biobanking Services Sales Value by Country (%), 2025 vs 2032
5.3 Europe
5.3.1 Europe Biobanking Services Sales Value, 2021–2032
5.3.2 Europe Biobanking Services Sales Value by Country (%), 2025 vs 2032
5.4 Asia Pacific
5.4.1 Asia Pacific Biobanking Services Sales Value, 2021–2032
5.4.2 Asia Pacific Biobanking Services Sales Value by Subregion (%), 2025 vs 2032
5.5 South America
5.5.1 South America Biobanking Services Sales Value, 2021–2032
5.5.2 South America Biobanking Services Sales Value by Country (%), 2025 vs 2032
5.6 Middle East & Africa
5.6.1 Middle East & Africa Biobanking Services Sales Value, 2021–2032
5.6.2 Middle East & Africa Biobanking Services Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Biobanking Services Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Biobanking Services Sales Value, 2021–2032
6.3 United States
6.3.1 United States Biobanking Services Sales Value, 2021–2032
6.3.2 United States Biobanking Services Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Biobanking Services Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Biobanking Services Sales Value, 2021–2032
6.4.2 Europe Biobanking Services Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Biobanking Services Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Biobanking Services Sales Value, 2021–2032
6.5.2 China Biobanking Services Sales Value by Type (%), 2025 vs 2032
6.5.3 China Biobanking Services Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Biobanking Services Sales Value, 2021–2032
6.6.2 Japan Biobanking Services Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Biobanking Services Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Biobanking Services Sales Value, 2021–2032
6.7.2 South Korea Biobanking Services Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Biobanking Services Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Biobanking Services Sales Value, 2021–2032
6.8.2 Southeast Asia Biobanking Services Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Biobanking Services Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Biobanking Services Sales Value, 2021–2032
6.9.2 India Biobanking Services Sales Value by Type (%), 2025 vs 2032
6.9.3 India Biobanking Services Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Qiagen N.V.
7.1.1 Qiagen N.V. Profile
7.1.2 Qiagen N.V. Main Business
7.1.3 Qiagen N.V. Biobanking Services Products, Services, and Solutions
7.1.4 Qiagen N.V. Biobanking Services Revenue (US$ Million), 2021–2026
7.1.5 Qiagen N.V. Recent Developments
7.2 Hamilton
7.2.1 Hamilton Profile
7.2.2 Hamilton Main Business
7.2.3 Hamilton Biobanking Services Products, Services, and Solutions
7.2.4 Hamilton Biobanking Services Revenue (US$ Million), 2021–2026
7.2.5 Hamilton Recent Developments
7.3 Brooks Automation
7.3.1 Brooks Automation Profile
7.3.2 Brooks Automation Main Business
7.3.3 Brooks Automation Biobanking Services Products, Services, and Solutions
7.3.4 Brooks Automation Biobanking Services Revenue (US$ Million), 2021–2026
7.3.5 Brooks Automation Recent Developments
7.4 TTP Labtech
7.4.1 TTP Labtech Profile
7.4.2 TTP Labtech Main Business
7.4.3 TTP Labtech Biobanking Services Products, Services, and Solutions
7.4.4 TTP Labtech Biobanking Services Revenue (US$ Million), 2021–2026
7.4.5 TTP Labtech Recent Developments
7.5 VWR
7.5.1 VWR Profile
7.5.2 VWR Main Business
7.5.3 VWR Biobanking Services Products, Services, and Solutions
7.5.4 VWR Biobanking Services Revenue (US$ Million), 2021–2026
7.5.5 VWR Recent Developments
7.6 Promega
7.6.1 Promega Profile
7.6.2 Promega Main Business
7.6.3 Promega Biobanking Services Products, Services, and Solutions
7.6.4 Promega Biobanking Services Revenue (US$ Million), 2021–2026
7.6.5 Promega Recent Developments
7.7 LGC
7.7.1 LGC Profile
7.7.2 LGC Main Business
7.7.3 LGC Biobanking Services Products, Services, and Solutions
7.7.4 LGC Biobanking Services Revenue (US$ Million), 2021–2026
7.7.5 LGC Recent Developments
7.8 Boca Biolistics
7.8.1 Boca Biolistics Profile
7.8.2 Boca Biolistics Main Business
7.8.3 Boca Biolistics Biobanking Services Products, Services, and Solutions
7.8.4 Boca Biolistics Biobanking Services Revenue (US$ Million), 2021–2026
7.8.5 Boca Biolistics Recent Developments
7.9 Thermo Fisher
7.9.1 Thermo Fisher Profile
7.9.2 Thermo Fisher Main Business
7.9.3 Thermo Fisher Biobanking Services Products, Services, and Solutions
7.9.4 Thermo Fisher Biobanking Services Revenue (US$ Million), 2021–2026
7.9.5 Thermo Fisher Recent Developments
8 Industry Chain Analysis
8.1 Biobanking Services Value Chain
8.2 Biobanking Services Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Cost Structure
8.3 Midstream Analysis
8.4 Downstream (Customer) Analysis
8.5 Sales Model and Sales Channelss
8.5.1 Biobanking Services Sales Model
8.5.2 Sales Channels
8.5.3 Biobanking Services Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Biobanking Services market was valued at US$ 3016 million in 2025 and is anticipated to reach US$ 4905 million by 2032, at a CAGR of 7.3% from 2026 to 2032.
Published Date: 2026-04-28
Pages: 105
USD 2900.00
(Single User License)
The global Biobanking Services market size was US$ 2830 million in 2024 and is forecast to a readjusted size of US$ 4603 million by 2031 with a CAGR of 7.3% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 79
USD 4250.00
(Single User License)
The global market for Biobanking Services was valued at US$ 2830 million in the year 2024 and is projected to reach a revised size of US$ 4603 million by 2031, growing at a CAGR of 7.3% during the forecast period.
Published Date: 2025-02-27
Pages: 77
USD 2900.00
(Single User License)
The global market for Biobanking Services was estimated to be worth US$ 2830 million in 2024 and is forecast to a readjusted size of US$ 4603 million by 2031 with a CAGR of 7.3% during the forecast period 2025-2031.
Published Date: 2025-02-27
Pages: 96
USD 3950.00
(Single User License)
Biobanking is a procedure to collect and preserve biological materials that can be further used for diagnosis, biodiversity studies, and research.
Published Date: 2024-04-26
Pages: 88
USD 4900.00
(Single User License)
Biobanking is a procedure to collect and preserve biological materials that can be further used for diagnosis, biodiversity studies, and research.
Published Date: 2024-01-31
Pages: 71
USD 2900.00
(Single User License)
Biobanking is a procedure to collect and preserve biological materials that can be further used for diagnosis, biodiversity studies, and research.
Published Date: 2024-01-24
Pages: 97
USD 3950.00
(Single User License)
The global Biobanking Services market was valued at US$ 3016 million in 2025 and is anticipated to reach US$ 4905 million by 2032, at a CAGR of 7.3% from 2026 to 2032.
Published: 2026-04-28
Pages: 105
The global Biobanking Services market size was US$ 2830 million in 2024 and is forecast to a readjusted size of US$ 4603 million by 2031 with a CAGR of 7.3% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 79
The global market for Biobanking Services was valued at US$ 2830 million in the year 2024 and is projected to reach a revised size of US$ 4603 million by 2031, growing at a CAGR of 7.3% during the forecast period.
Published: 2025-02-27
Pages: 77
The global market for Biobanking Services was estimated to be worth US$ 2830 million in 2024 and is forecast to a readjusted size of US$ 4603 million by 2031 with a CAGR of 7.3% during the forecast period 2025-2031.
Published: 2025-02-27
Pages: 96
Biobanking is a procedure to collect and preserve biological materials that can be further used for diagnosis, biodiversity studies, and research.
Published: 2024-04-26
Pages: 88
Biobanking is a procedure to collect and preserve biological materials that can be further used for diagnosis, biodiversity studies, and research.
Published: 2024-01-31
Pages: 71
Biobanking is a procedure to collect and preserve biological materials that can be further used for diagnosis, biodiversity studies, and research.
Published: 2024-01-24
Pages: 97
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now